0000000000247255
AUTHOR
D. Deleanu
Positioning the principles of precision medicine in care pathways for allergic rhinitis and chronic rhinosinusitis â A EUFOREA-ARIA-EPOS-AIRWAYS ICP statement
Precision medicine (PM) is increasingly recognized as the way forward for optimizing patient care. Introduced in the field of oncology, it is now considered of major interest in other medical domains like allergy and chronic airway diseases, which face an urgent need to improve the level of disease control, enhance patient satisfaction and increase effectiveness of preventive interventions. The combination of personalized care, prediction of treatment success, prevention of disease and patient participation in the elaboration of the treatment plan is expected to substantially improve the therapeutic approach for individuals suffering from chronic disabling conditions. Given the emerging dat…
Integrated care pathways for airway diseases (AIRWAYS-ICPs)
International audience; The objective of Integrated Care Pathways for Airway Diseases (AIRWAYS-ICPs) is to launch a collaboration to develop multi-sectoral care pathways for chronic respiratory diseases in European countries and regions. AIRWAYS-ICPs has strategic relevance to the European Union Health Strategy and will add value to existing public health knowledge by: 1) proposing a common framework of care pathways for chronic respiratory diseases, which will facilitate comparability and trans-national initiatives; 2) informing cost-effective policy development, strengthening in particular those on smoking and environmental exposure; 3) aiding risk stratification in chronic disease patien…
MACVIA-ARIA Sentinel NetworK for allergic rhinitis (MASK-rhinitis): the new generation guideline implementation
Accepted Article
MOESM1 of Scaling up strategies of the chronic respiratory disease programme of the European Innovation Partnership on Active and Healthy Ageing (Action Plan B3: Area 5)
Additional file 1. IPCRG scaling up activities.
Scaling up strategies of the chronic respiratory disease programme of the European Innovation Partnership on Active and Healthy Ageing (Action Plan B3: Area 5)
Action Plan B3 of the European Innovation Partnership on Active and Healthy Ageing (EIP on AHA) focuses on the integrated care of chronic diseases. Area 5 (Care Pathways) was initiated using chronic respiratory diseases as a model. The chronic respiratory disease action plan includes (1) AIRWAYS integrated care pathways (ICPs), (2) the joint initiative between the Reference site MACVIA-LR (Contre les MAladies Chroniques pour un VIeillissement Actif) and ARIA (Allergic Rhinitis and its Impact on Asthma), (3) Commitments for Action to the European Innovation Partnership on Active and Healthy Ageing and the AIRWAYS ICPs network. It is deployed in collaboration with the World Health Organizatio…
Electromagnetic transition rates in theN=80nucleus58138Ce
The half-life of the Iπ=6+ yrast state at Ex=2294 keV in 138Ce has been measured as T1/2=880(19) ps using the fast-timing γ-ray coincidence method with a mixed LaBr3(Ce)-HPGe array. The excited states in 138Ce have been populated by the 130Te(12C,4n) fusion-evaporation reaction at an incident beam energy of 56 MeV. The extracted B(E2;61+→41+)=0.101(24) W.u. value is compared with the predictions of truncated basis shell model calculations and with the systematics of the region. This shows an anomalous behavior compared to the neighboring isotonic and isotopic chains. Half-lives for the yrast 5-, 11+ and 14+ states in 138Ce have also been determined in this work.
ARIA 2016: Care pathways implementing emerging technologies for predictive medicine in rhinitis and asthma across the life cycle
The Allergic Rhinitis and its Impact on Asthma (ARIA) initiative commenced during a World Health Organization workshop in 1999. The initial goals were (1) to propose a new allergic rhinitis classification, (2) to promote the concept of multi-morbidity in asthma and rhinitis and (3) to develop guidelines with all stakeholders that could be used globally for all countries and populations. ARIA-disseminated and implemented in over 70 countries globally-is now focusing on the implementation of emerging technologies for individualized and predictive medicine. MASK [MACVIA (Contre les Maladies Chroniques pour un Vieillissement Actif)-ARIA Sentinel NetworK] uses mobile technology to develop care p…
Manifesto on small airway involvement and management in asthma and chronic obstructive pulmonary disease: an Interasma (Global Asthma Association - GAA) and World Allergy Organization (WAO) document endorsed by Allergic Rhinitis and its Impact on Asthma (ARIA) and Global Allergy and Asthma European Network (GA2LEN)
International audience; Evidence that enables us to identify, assess, and access the small airways in asthma and chronic obstructive pulmonary disease (COPD) has led INTERASMA (Global Asthma Association) and WAO to take a position on the role of the small airways in these diseases. Starting from an extensive literature review, both organizations developed, discussed, and approved the manifesto, which was subsequently approved and endorsed by the chairs of ARIA and GA2LEN. The manifesto describes the evidence gathered to date and defines and proposes issues on small airway involvement and management in asthma and COPD with the aim of challenging assumptions, fostering commitment, and bringin…
Guidance to 2018 good practice: ARIA digitally-enabled, integrated, person-centred care for rhinitis and asthma
AIMS: Mobile Airways Sentinel NetworK (MASK) belongs to the Fondation Partenariale MACVIA-LR of Montpellier, France and aims to provide an active and healthy life to rhinitis sufferers and to those with asthma multimorbidity across the life cycle, whatever their gender or socio-economic status, in order to reduce health and social inequities incurred by the disease and to improve the digital transformation of health and care. The ultimate goal is to change the management strategy in chronic diseases. METHODS: MASK implements ICT technologies for individualized and predictive medicine to develop novel care pathways by a multi-disciplinary group centred around the patients. STAKEHOLDERS: Incl…
Precision Lifetime Measurements Using LaBr3 Detectors With Stable and Radioactive Beams
A range of high resolution gamma-ray spectroscopy measurements have been carried out using arrays which include a number of Cerium-doped Lanthanum-Tribromide (LrBr3 (Ce)) scintillation detectors used in conjunction with high-resolution hyper-pure germanium detectors. Examples of the spectral and temporal responses of such set-ups, using both standard point radioactive sources 152 Eu and 56 Co, and in-beam fusionevaporation reaction experiments for precision measurements of nuclear excited states in 34 P and 138 Ce are presented. The current and future use of such arrays at existing (EURICA at RIKEN) and future (NUSTAR at FAIR) secondary radioactive beam facilities for precision measurements…
Electromagnetic Transition Rate Measurements in theN=80 Isotone,138Ce
A study of intrinsic state halflife measurements in the N=80 nucleus 138Ce has been made using the 130Te(12C,4n)138Ce fusion evaporation reaction at beam energy of 56 MeV. The fast-timing gamma-ray coincidence method was used with a mixed LaBr3(Ce)-HPGe array to establish the lifetimes of the yrast 6+ state at 2294 keV, the Iπ=5− state at 2218 keV, the Iπ=11+ state at 3943 keV and the 14+ state at that at 5312 keV, all of which are in the sub nanosecond regime. Reduced transition probabilities have been calculated for the electromagnetic decays from these states.